352 related articles for article (PubMed ID: 20010493)
1. Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness.
Maes M; Mihaylova I; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
Neuro Endocrinol Lett; 2009; 30(4):462-9. PubMed ID: 20010493
[TBL] [Abstract][Full Text] [Related]
2. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder.
Maes M; Mihaylova I; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
Neuro Endocrinol Lett; 2009; 30(4):470-6. PubMed ID: 20010505
[TBL] [Abstract][Full Text] [Related]
3. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS.
Maes M; Twisk FN
Neuro Endocrinol Lett; 2009; 30(6):677-93. PubMed ID: 20038921
[TBL] [Abstract][Full Text] [Related]
4. Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression.
Maes M; Mihaylova I; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
Neuro Endocrinol Lett; 2011; 32(2):133-40. PubMed ID: 21552194
[TBL] [Abstract][Full Text] [Related]
5. Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression.
Maes M; Mihaylova I; Leunis JC
Neuro Endocrinol Lett; 2007 Dec; 28(6):861-7. PubMed ID: 18063934
[TBL] [Abstract][Full Text] [Related]
6. Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: a case series.
Bouwer C; Claassen J; Dinan TG; Nemeroff CB
Depress Anxiety; 2000; 12(1):44-50. PubMed ID: 10999245
[TBL] [Abstract][Full Text] [Related]
7. Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients.
Maes M; Ruckoanich P; Chang YS; Mahanonda N; Berk M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):769-83. PubMed ID: 20561554
[TBL] [Abstract][Full Text] [Related]
8. Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression.
Maes M; Mihaylova I; Kubera M; Ringel K
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):169-75. PubMed ID: 21945535
[TBL] [Abstract][Full Text] [Related]
9. Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome.
Maes M; Mihaylova I; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Aug; 28(4):463-9. PubMed ID: 17693978
[TBL] [Abstract][Full Text] [Related]
10. Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression.
Rusciani L; Proietti I; Rusciani A; Paradisi A; Sbordoni G; Alfano C; Panunzi S; De Gaetano A; Lippa S
J Am Acad Dermatol; 2006 Feb; 54(2):234-41. PubMed ID: 16443053
[TBL] [Abstract][Full Text] [Related]
11. "Functional" or "psychosomatic" symptoms, e.g. a flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression.
Maes M
Neuro Endocrinol Lett; 2009; 30(5):564-73. PubMed ID: 20035251
[TBL] [Abstract][Full Text] [Related]
12. An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbidity between major depression and CFS.
Maes M; Mihaylova I; Kubera M; Leunis JC
Neuro Endocrinol Lett; 2008 Jun; 29(3):313-9. PubMed ID: 18580855
[TBL] [Abstract][Full Text] [Related]
13. Association between type D personality, depression, and oxidative stress in patients with chronic heart failure.
Kupper N; Gidron Y; Winter J; Denollet J
Psychosom Med; 2009 Nov; 71(9):973-80. PubMed ID: 19834046
[TBL] [Abstract][Full Text] [Related]
14. Comparison of coenzyme Q10 plasma levels in obese and normal weight children.
Menke T; Niklowitz P; de Sousa G; Reinehr T; Andler W
Clin Chim Acta; 2004 Nov; 349(1-2):121-7. PubMed ID: 15469864
[TBL] [Abstract][Full Text] [Related]
15. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
16. A pilot clinical trial of the effects of coenzyme Q10 on chronic tinnitus aurium.
Khan M; Gross J; Haupt H; Jainz A; Niklowitz P; Scherer H; Schmidt FP; Klapp BF; Reisshauer A; Mazurek B
Otolaryngol Head Neck Surg; 2007 Jan; 136(1):72-7. PubMed ID: 17210337
[TBL] [Abstract][Full Text] [Related]
17. Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta.
Maes M; Mihaylova I; Bosmans E
Neuro Endocrinol Lett; 2007 Aug; 28(4):456-62. PubMed ID: 17693979
[TBL] [Abstract][Full Text] [Related]
18. Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients.
Sakata T; Furuya R; Shimazu T; Odamaki M; Ohkawa S; Kumagai H
Blood Purif; 2008; 26(4):371-8. PubMed ID: 18509244
[TBL] [Abstract][Full Text] [Related]
19. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.
Maes M; Galecki P; Chang YS; Berk M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):676-92. PubMed ID: 20471444
[TBL] [Abstract][Full Text] [Related]
20. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.
Amsterdam JD; Shults J; Rutherford N
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):100-6. PubMed ID: 17804135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
